Literature DB >> 3794533

Arterial embolization for control of bleeding in advanced head and neck carcinoma.

S Bhansali, H Wilner, J R Jacobs.   

Abstract

There are a number of patients with unresectable recurrent carcinoma of the head and neck who continue to lead a relatively functional life despite advanced local disease. For these patients bleeding from tumor represents a devastating complication that can abruptly terminate the course of an otherwise chronic disease, albeit a uniformly fatal one. The technique we describe renders a relatively safe and effective treatment that seems to control this problem. We report on our experience with three patients whose tumor bleeding was controlled by permanent intra-arterial embolization with Ivalon, a polyvinyl alcohol-based foam. The technique, indications, and complications are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3794533     DOI: 10.1017/s0022215100100994

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Transcutaneous arterial embolization to control massive tumor bleeding in head and neck cancer: 63 patients' experiences from a single medical center.

Authors:  Wen-Chi Chou; Chang-Hsien Lu; Gigin Lin; Yu-Shin Hong; Ping-Tsung Chen; Hung-Chih Hsu; Jen-Shi Chen; Kun-Yun Yeh; Hung-Ming Wang; Chuang-Chi Liaw
Journal:  Support Care Cancer       Date:  2007-03-14       Impact factor: 3.603

2.  CT angiography before embolization for hemorrhage in head and neck cancer.

Authors:  Daniel N Goodman; Brian L Hoh; James D Rabinov; Johnny C Pryor
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

3.  The calcium-phosphate balance, modulation of thyroid autoimmune processes and other adverse effects connected with thyroid arterial embolization.

Authors:  Grzegorz Kaminski; Andrzej Jaroszuk; Ariadna Zybek; Krzysztof Brzozowski; Piotr Piasecki; Piotr Ziecina; Marek Ruchala
Journal:  Endocrine       Date:  2013-10-22       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.